Rogers, Kerry A., Philip A. Thompson, John N. Allan, Morton Coleman, Jeff P. Sharman, Bruce D. Cheson, Daniel Jones, Raquel Izumi, Melanie M. Frigault, Cheng Quah, Rakesh K. Raman, Priti Patel, Min Hui Wang, and Thomas J. Kipps. 2021. “Phase II Study of Acalabrutinib in Ibrutinib-Intolerant Patients With relapsed/Refractory Chronic Lymphocytic Leukemia”. Haematologica 106 (9). Pavia, Italy, 2364-73. https://doi.org/10.3324/haematol.2020.272500.